Powerpoint Presentation - PharmAdvices
Download
Report
Transcript Powerpoint Presentation - PharmAdvices
20070327 1/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF
(CLINICAL) INVESTIGATORS
Prof. JanHasker G. Jonkman,
Ph.D., F.C.P., F.R.Q.A., R.Ph.,
Clinical Pharmacologist
University of Groningen (NL)
Professor Quality Management in Drug Research and Manufacturing
Stichting Certificering Klinisch Wetenschappelijk Onderzoeker
JHGJ/gh
20070327 2/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 3/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 4/50
CERTIFICATION OF INVESTIGATORS
GENERAL (1)
Definition:
• Certification is the official proof - in writing
and confirmed by signature - of the presence
of knowledge and the ability to perform
JHGJ/gh
20070327 5/50
CERTIFICATION OF INVESTIGATORS
GENERAL (2)
A high quality clinical study has to be performed
in accordance with:
• Appropriate ethical standards
• Appropriate medical standards
• Appropriate scientific standards
• Appropriate legal standards
• Appropriate regulatory standards
JHGJ/gh
20070327 6/50
CERTIFICATION OF INVESTIGATORS
GENERAL (3)
High quality clinical study data require Investigators with:
• Superior medical professional knowledge and skills
for the safe conduct of a clinical study
• Solid knowledge of Good Research Practices for
an ethical conduct of a clinical study
JHGJ/gh
20070327 7/50
CERTIFICATION OF INVESTIGATORS
GENERAL (4)
Are required knowledge and skills present? (1)
• Investigators sign Form 1572 (FDA) declaring that
they are qualified to conduct
and
are fully responsible for all aspects of the clinical study
JHGJ/gh
20070327 8/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 9/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 10/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 11/50
CERTIFICATION OF INVESTIGATORS
GENERAL (5)
Are required knowledge and skills present? (2)
• There is examination of medical knowledge and
professional skills
but
• There is no examination of knowledge and skills on
clinical research (‘Good Research Practices’)
JHGJ/gh
20070327 12/50
CERTIFICATION OF INVESTIGATORS
GENERAL (6)
‘These are the issues clinical trial sites are
struggling with based on my inspections.
But number one on the list is lack of GCP
knowledge and training’
Mike M. Rashti,
Food and Drug Administration, FDA, USA, 2006
JHGJ/gh
20070327 13/50
CERTIFICATION OF INVESTIGATORS
GENERAL (7)
‘The single most important step we could take
to improve clinical trials….. is to make sure that
those doing the research are qualified to do it’
Greg Koski,
Former Director of Office of Human
Research Protections, OHRP, USA, 2004
JHGJ/gh
20070327 14/50
CERTIFICATION OF INVESTIGATORS
GENERAL (8)
‘Heute ist die Durchführung Klinischer Prüfungen
ohne Spezialkenntnisse gar nicht denkbar’
Dr. Med. Norbert Clemens,
Bundesvorsitzender der Deutschen Gesellschaft
für Pharmazeutische Medizin e.V.
(DG PharMed, 2007)
JHGJ/gh
20070327 15/50
CERTIFICATION OF INVESTIGATORS
Source: The CenterWatch Monthly, November 2006
JHGJ/gh
20070327 16/50
CERTIFICATION OF INVESTIGATORS
Source: The CenterWatch Monthly, November 2006
JHGJ/gh
20070327 17/50
CERTIFICATION OF INVESTIGATORS
Source: The CenterWatch Monthly, November 2006
JHGJ/gh
20070327 18/50
CERTIFICATION OF INVESTIGATORS
GENERAL (9)
Training - The Netherlands
• University Groningen (+ University Utrecht)
GUIDE - Course ‘Good Research Practices GCP/GLP’
(since 1993)
Post graduate course
also open to external professionals
• Several commercial (in-house) courses
JHGJ/gh
20070327 19/50
CERTIFICATION OF INVESTIGATORS
Source: Good Clinical Practice Journal, September 2004, p19-22
JHGJ/gh
20070327 20/50
CERTIFICATION OF INVESTIGATORS
GENERAL (10)
Definition:
• Certification is the official proof - in writing
and confirmed by signature - of the presence
of knowledge and the ability to perform
JHGJ/gh
20070327 21/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 22/50
CERTIFICATION OF INVESTIGATORS
GENERAL (11)
Reasons for Certification (1)
• May improve safety of subjects
• May improve quality data
• Conveys a commitment to clinical research
• Provides assurance to Sponsor, authorities,
Medical Ethics Committees, study participants
and editors of journals that investigator understands
requirements of GCP etc.
JHGJ/gh
20070327 23/50
CERTIFICATION OF INVESTIGATORS
GENERAL (12)
Reasons for Certification (2)
• (Together with training): intellectual stimulation /
professional development
• Business advantage (for ‘commercial’ Investigators)
(N.B. In The Netherlands the law requires that an investigator has a
certificate in order to be allowed to perform animal experiments; ‘Art. 9’)
JHGJ/gh
20070327 24/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 25/50
CERTIFICATION OF INVESTIGATORS
HISTORY (1)
• USA
ACRP* (Association of Clinical Research Professionals)
1992: certification of Clinical Research Co-ordinations (CRCs)
1995: certification of Clinical Research Associates (CRAs)
2002: certification of Physician Investigators (PI)
approximately 14.000 people certified
* www.ACRPnet.org
JHGJ/gh
20070327 26/50
CERTIFICATION OF INVESTIGATORS
HISTORY (2)
• USA
DIA* (Drug Information Association)
2002: certification of Clinical Investigators
SOCRA** (Society of Clinical Research Associates)
1995: certification of Clinical Research Professionals
AAPP (American Academy of Pharmaceutical Physicians)
APPI (Academy of Pharmaceutical Physicians
and Investigators; until 2003: AAPP = American Academy
of Pharmaceutical Physicians)
2003: certification of Physician Investigators
* www.diahome.org
** www.SOCRA.org
JHGJ/gh
20070327 27/50
CERTIFICATION OF INVESTIGATORS
HISTORY (3)
• USA
• 2006:
Certification programs of DIA and APPI have been
consolidated with ACRP programme resulting in two
new affiliates of ACRP:
Academy of Clinical Research Professionals
(The Academy) for certification of non-physicians
(CCRA = Certified Clinical Research Associate;
CCRC = Certified Clinical Research Coordinator)
APPI for certification of physicians
(CPI = Certified Physician Investigator)
JHGJ/gh
20070327 28/50
CERTIFICATION OF INVESTIGATORS
HISTORY (4)
• USA
total number of certificates: approximately 17.500
of which physicians approximately 400
JHGJ/gh
20070327 29/50
CERTIFICATION OF INVESTIGATORS
HISTORY (5)
• Europe
ACRP
ECCRT (European Centre for Clinical Research Training)
JHGJ/gh
20070327 30/50
CERTIFICATION OF INVESTIGATORS
HISTORY (6)
• Germany
DG PharMed
• The Netherlands
GUIDE* Graduate School for Drug Exploration
Certificate ‘Good Research Practices GCP / GLP’
University of Groningen
• Belgium
PHARMED** Post-graduate programme in pharmacology
and pharmaceutical medicine (University Brussels)
* www.rug.nl/guide or www.pharmadvices.com
**ulb.ac.be/medicine/pharmedwww
JHGJ/gh
20070327 31/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 32/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (1)
New initiative for e-learning / e-testing / certification GCP (1)
• 2004:
Prof.Dr. JanHasker G. Jonkman, University of Groningen
Drs. Bert Harenberg, MediaVision, Laren
JHGJ/gh
20070327 33/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (2)
New initiative for e-learning / e-testing / certification GCP (2)
• 2005:
other founding members (‘Initiating Group’)
Dr. Helena van den Dungen (Dutch GCP Inspectorate)
Dr. Herman Pieterse (GCP Consultant)
Cecilia Huisman (ACRP; NVRV)
Dr. Philip Salden (Nefarma)
Dr. Rudolf van Olden (NVFG)
Drs. Pieter Guelen (ACRON)
completion of a printed ‘proposal’ entitled
‘GCP - The necessity of GCP-examination in The Netherlands’
JHGJ/gh
20070327 34/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 35/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (3)
• 2006 (1):
verbal commitment CCMO (Dr. M. Kenter)
contacts with NFU (Nederlandse Federatie Universiteiten; UMCs)
intention for a cooperation to design an exam in line
with requirements of NFU (subject: ‘Wet en Regelgeving’)
JHGJ/gh
20070327 36/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (4)
• 2006 (2):
On November 09;
Stichting Certificering Klinisch Wetenschappelijk Onderzoeker
(Foundation for Certification of Clinical Researchers)
residence:
Assen
board:
Prof.Dr. J.H.G. Jonkman
Prof.Dr. R.A. de Zeeuw
Dr. R.W. van Olden
JHGJ/gh
20070327 37/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (5)
Stichting CKWO: Objectives
1. a. To improve the quality of clinical research
in The Netherlands as well as elsewhere
b. To perform all actions that will be necessary to reach
the above mentioned objective
2. a. To establish and maintain a system for certification
of clinical researchers
b. To establish a system for examination in order
to reach this objective of certification
3. The Foundation is a non-profit organization
JHGJ/gh
20070327 38/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (6)
• 2006 (3):
Start of Editiorial Board
prepare first three exams
extended with two members on behalf of the NFU
Dr. Mieke Trip (AMC)
Dr. A.J.M. Craen (UMCL)
Dr. Rudolf van Olden was replaced by
Drs. Alexandra Smeur-van Andel
JHGJ/gh
20070327 39/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (7)
Concept of exam:
• ‘Learning by Testing’
• Each exam consists of different ‘test cases’
• A 3-minutes video of a ‘real life’ situation (during
a clinical study) followed by 3-5 multiple choice
questions (= ‘Testing’)
When the answer is wrong, the right answer will be
given by the computer (= ‘Learning’)
JHGJ/gh
20070327 40/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (8)
The system of examination will fulfil the following
requirements (1):
• Individual training (‘Learning by Testing’)
• Modular system with different test cases and different
small certificates (‘deelcertificaten’), together forming
the full certificate
• Flexible system: large freedom for candidate to
choose modules in own order
choose time and place of examination
JHGJ/gh
20070327 41/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (9)
The system of examination will fulfil the following
requirements (2):
• Test cases should be interesting and stimulating
(motivating)
• It should be able to test not only knowledge of rules
and laws, but in particular to test ‘GCP-mentality’
JHGJ/gh
20070327 42/50
CERTIFICATION OF INVESTIGATORS
PRESENT SITUATION: THE NETHERLANDS (10)
The system of examination will fulfil the following
requirements (3):
• 2007
June:
first ‘try-out’ of examination in University
Medical Center Amsterdam (AMC)
(with three different video’s / test cases)
JHGJ/gh
20070327 43/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 44/50
CERTIFICATION OF INVESTIGATORS
JHGJ/gh
20070327 45/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 46/50
CERTIFICATION OF INVESTIGATORS
FUTURE (1)
• Prepare a publicly available list of ‘Certified Clinical
Researchers’ (open to the public including all
stakeholders like: Sponsors, authorities, Medical Ethics
Committees, potential study participants, editors of
journals, etc.)
• Obtain acknowledgement of the certificate by the
authorities e.g.: comparable with title ‘Clinical
Pharmacologist’ that is recognized in the WMO
(‘Wet Medisch-Wetenschappelijk Onderzoek met
Mensen’; ‘Law on Medical Research in Human Subjects’)
JHGJ/gh
20070327 47/50
CERTIFICATION OF INVESTIGATORS
FUTURE (2)
• More extensive use of the facilities of the web for the
examination
• May be extension to other area of Clinical Research
rather than only Good Clinical Practices
• May be extension to web-based training in Good
Research Practices (‘e-learning’)
• Hopefully the certification contributes to further
appreciation of The Netherlands as ‘clinical trial country’
JHGJ/gh
20070327 48/50
CERTIFICATION OF INVESTIGATORS
CERTIFICATION OF (CLINICAL) INVESTIGATORS
TABLE OF CONTENTS
• General
• History
• Present Situation
• Future
• Conclusions
JHGJ/gh
20070327 49/50
CERTIFICATION OF INVESTIGATORS
CONCLUSIONS (1)
• Solid training in clinical research is of paramount
importance
• There are many deficiencies in the knowledge of
several clinical researchers as far as ‘Good Research
Practices’ concerns
• The knowledge of the staff involved should be easily
recognized by other stakeholders (Sponsors, authorities,
Medical Ethics Committees, potential study participants,
editors of journals, etc.)
JHGJ/gh
20070327 50/50
CERTIFICATION OF INVESTIGATORS
CONCLUSIONS (2)
• All opportunities of ‘e-learning’ and ‘e-testing’
will be used for learning and examination
• Higher quality of clinical research staff will increase
the attractiveness of The Netherlands as clinical trial
country
JHGJ/gh